These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


364 related items for PubMed ID: 32496870

  • 1. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
    Jin D, Han F.
    J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
    [Abstract] [Full Text] [Related]

  • 2. Glaucocalyxin A attenuates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts.
    Su Q, Zhang Y.
    Biochem Biophys Res Commun; 2018 Sep 10; 503(3):1949-1954. PubMed ID: 30072098
    [Abstract] [Full Text] [Related]

  • 3. Diosgenin inhibits angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts through regulating the TGF‑β1/Smad3 signaling pathway.
    Zhou HT, Yu XF, Zhou GM.
    Mol Med Rep; 2017 May 10; 15(5):2823-2828. PubMed ID: 28260007
    [Abstract] [Full Text] [Related]

  • 4. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
    Li B, Chen H, Yang X, Wang Y, Qin L, Chu Y.
    Cell Mol Biol (Noisy-le-grand); 2016 Jun 30; 62(7):97-101. PubMed ID: 27453280
    [Abstract] [Full Text] [Related]

  • 5. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R, Chen Y, Xu Z, Zhang X.
    Coron Artery Dis; 2010 Sep 30; 21(6):369-77. PubMed ID: 20613497
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.
    Liu J, Zhuo X, Liu W, Wan Z, Liang X, Gao S, Yuan Z, Wu Y.
    Chem Biol Interact; 2015 Feb 05; 227():45-52. PubMed ID: 25559857
    [Abstract] [Full Text] [Related]

  • 7. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
    Ma J, Ma SY, Ding CH.
    Chin J Integr Med; 2017 May 05; 23(5):362-369. PubMed ID: 26956464
    [Abstract] [Full Text] [Related]

  • 8. NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF‑β1/Smad3 signaling pathway.
    Zhou H, Yu X, Zhou G.
    Mol Med Rep; 2017 Sep 05; 16(3):3551-3556. PubMed ID: 28713900
    [Abstract] [Full Text] [Related]

  • 9. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M, Pan X, Zou Q, Xia Y, Chen J, Hao Q, Wang H, Sun D.
    Cardiovasc Toxicol; 2016 Oct 05; 16(4):316-24. PubMed ID: 26487518
    [Abstract] [Full Text] [Related]

  • 10. Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts.
    Fu B, Su Y, Ma X, Mu C, Yu F.
    J Pharmacol Sci; 2018 Jun 05; 137(2):110-115. PubMed ID: 29921497
    [Abstract] [Full Text] [Related]

  • 11. Protocatechuic acid attenuates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the NOX4/ROS/p38 signaling pathway.
    Song H, Ren J.
    Phytother Res; 2019 Sep 05; 33(9):2440-2447. PubMed ID: 31318113
    [Abstract] [Full Text] [Related]

  • 12. The crystallin alpha B (HSPB5)-tripartite motif containing 33 (TRIM33) axis mediates myocardial fibrosis induced by angiotensinogen II through transforming growth factor-β (TGF-β1)-Smad3/4 signaling.
    Wei T, Du Y, Shan T, Chen J, Shi D, Yang T, Wang J, Zhang J, Li Y.
    Bioengineered; 2022 Apr 05; 13(4):8836-8849. PubMed ID: 35333698
    [Abstract] [Full Text] [Related]

  • 13. Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats.
    Li J, Ding H, Li Y, Zhou H, Wang W, Mei Y, Zhang R.
    Amino Acids; 2021 Jul 05; 53(7):1079-1089. PubMed ID: 34089389
    [Abstract] [Full Text] [Related]

  • 14. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D, Lei H, Wang JY, Zhang CL, Feng H, Fu FY, Li L, Wu LL.
    J Mol Med (Berl); 2015 Dec 05; 93(12):1311-25. PubMed ID: 26138247
    [Abstract] [Full Text] [Related]

  • 15. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
    Wu XP, Wang HJ, Wang YL, Shen HR, Tan YZ.
    Exp Cell Res; 2018 Jan 01; 362(1):17-27. PubMed ID: 28987540
    [Abstract] [Full Text] [Related]

  • 16. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
    Zeng Z, Wang Q, Yang X, Ren Y, Jiao S, Zhu Q, Guo D, Xia K, Wang Y, Li C, Wang W.
    Phytomedicine; 2019 Sep 01; 62():152949. PubMed ID: 31102891
    [Abstract] [Full Text] [Related]

  • 17. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
    Hu J, Zhang JJ, Li L, Wang SL, Yang HT, Fan XW, Zhang LM, Hu GL, Fu HX, Song WF, Yan LJ, Liu JJ, Wu JT, Kong B.
    J Cell Mol Med; 2021 Jul 01; 25(14):6746-6759. PubMed ID: 34132026
    [Abstract] [Full Text] [Related]

  • 18. Asenapine maleate inhibits angiotensin II-induced proliferation and activation of cardiac fibroblasts via the ROS/TGFβ1/MAPK signaling pathway.
    Wu HH, Meng TT, Chen JM, Meng FL, Wang SY, Liu RH, Chen JN, Ning B, Li Y, Su GH.
    Biochem Biophys Res Commun; 2021 May 14; 553():172-179. PubMed ID: 33773140
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-β1/Smad2/3 Induces Atrial Fibrosis in Aging and Spontaneously Hypertensive Rats.
    He R, Zhang J, Luo D, Yu Y, Chen T, Yang Y, Yu F, Li M.
    Oxid Med Cell Longev; 2019 May 14; 2019():4025496. PubMed ID: 31871548
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
    Lyu H, Li X, Wu Q, Hao L.
    J Pharmacol Sci; 2019 Sep 14; 141(1):70-78. PubMed ID: 31611175
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.